Market cap: $5.1 billion
What it does: Big data analytics
MEGA THREAD\U0001f9f5
— Brian Feroldi (@BrianFeroldi) April 25, 2021
My Mission: To Spread Financial Wellness
All of my best threads on money, investing, and self-improvement can be found below
*This list will be continually updated \u2b07\ufe0f
What company is worth less than $10 billion today but you think could be worth $500+ billion in a few decades?
— Brian Feroldi (@BrianFeroldi) July 8, 2021
\u201cA genuine intention to solve a problem\u201d is the best startup strategy you can have.
— Al Caan (@caan_al) January 15, 2022
Do not lose sight of the intention behind your service, as you scale up.
$600 Client \u2014 Complain, complain, complain
— Will Cannon (@iamwillcannon) September 12, 2021
$60,000 Client \u2014 \u201cMoney sent, thanks\u201d
Beginner\u2019s Dilemma:
— Barrett O'Neill (@barrettjoneill) February 6, 2022
New endeavors are so challenging that other options appear an easier route to success.
If you choose to switch, rather than iterate and optimize, you\u2019ll always be a beginner.
And things will always seem hard.
90% of new startups fail.
— Chris Munn (@chrisxmunn) February 4, 2022
Consider buying a business instead.
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz